3165:HK:HK-ChinaAMC MSCI Europe Quality Hedged to USD ETF (HKD)

ETF | Others |

Last Closing

USD 18.46

Change

+0.01 (+0.05)%

Market Cap

N/A

Volume

200.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.17 (+0.96%)

USD 137.98B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+0.50 (+0.81%)

USD 22.56B
2801:HK iShares Core MSCI China ETF

+0.15 (+0.85%)

USD 13.97B
2823:HK iShares FTSE A50 China

-0.09 (-0.75%)

USD 13.65B
83188:HK ChinaAMC CSI 300 Index ETF

-0.06 (-0.18%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

+0.01 (+0.75%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

+0.04 (+0.48%)

USD 9.22B
82822:HK CSOP FTSE China A50

-0.03 (-0.29%)

USD 7.65B
9010:HK iShares Core MSCI AC Asia ex J..

+0.08 (+1.10%)

USD 3.03B

ETFs Containing 3165:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.21% 79% B- 78% C+
Dividend Return 0.24% 2% F 1% F
Total Return 10.45% 77% C+ 76% C+
Trailing 12 Months  
Capital Gain 13.67% 81% B- 80% B-
Dividend Return 1.79% 17% F 15% F
Total Return 15.46% 81% B- 89% A-
Trailing 5 Years  
Capital Gain 55.13% 81% B- 86% B+
Dividend Return 7.39% 61% D- 24% F
Total Return 62.52% 85% B 84% B
Average Annual (5 Year Horizon)  
Capital Gain 9.43% 84% B 73% C
Dividend Return 10.55% 84% B 72% C
Total Return 1.12% 34% F 25% F
Risk Return Profile  
Volatility (Standard Deviation) 12.88% 72% C 89% A-
Risk Adjusted Return 81.91% 96% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.